Posted by Michael Wonder on 19 Dec 2017
Republican bill to reduce tax credits for rare disease drugs
18 December 2017 - The target comes as a surprise under a Republican administration that has shown little interest in addressing high drug prices.
The final Republican tax bill, which should head to a vote this week, proposes a big cut to tax credits that are used to develop rare disease drugs.
Under current policy, pharmaceutical and biotech companies are allowed a tax credit of up to 50% of certain research costs for rare disease drugs.
